<DOC>
	<DOCNO>NCT00022139</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy , paclitaxel , carboplatin , fluorouracil , work different way stop tumor cell divide stop grow die . Giving radiation therapy chemotherapy give surgery may shrink tumor remove surgery . PURPOSE : This phase II trial study well give radiation therapy together combination chemotherapy follow esophagectomy work treat patient locally advanced cancer esophagus gastroesophageal junction .</brief_summary>
	<brief_title>Radiation Therapy Paclitaxel , Carboplatin , Fluorouracil Followed Esophagectomy Treating Patients With Locally Advanced Cancer Esophagus Gastroesophageal Junction</brief_title>
	<detailed_description>OBJECTIVES : - Determine pathologic complete response rate patient locally advanced cancer esophagus gastroesophageal junction treat radiotherapy administer concurrently paclitaxel , carboplatin , fluorouracil esophagectomy . - Determine tolerability regimen patient . - Determine tumor response rate patient treat regimen . - Determine quality life patient treat regimen . - Assess relationship presence genetic polymorphism patient toxicity regimen . OUTLINE : This multicenter study . Patients receive carboplatin IV paclitaxel IV 3 hour day 1 22 fluorouracil IV continuously day 1-42 . Beginning day 1 chemotherapy , patient undergo radiotherapy esophagus 5 day week 5 week . Treatment continue absence disease progression unacceptable toxicity . Patients stable respond disease 4-8 week completion radiotherapy undergo esophagectomy complete dissection mediastinal perigastric lymph node . Beginning 8 week surgery , patient underwent curative resection may receive maximum 2 additional course paclitaxel carboplatin absence disease progression unacceptable toxicity . Quality life assess baseline , chemotherapy day 1 22 , within 2 week surgery . Patients follow every 3 month 4 year .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm squamous cell carcinoma adenocarcinoma thoracic esophagus ( 20 cm ) gastroesophageal junction Surgically resectable disease ( T13 ; NX , N0 , N1 ; M1a ) T4 tumor unequivocally unresectable allow Celiac lymph node ( station 1520 ) involvement allow Must consider potential surgical candidate thoracic general surgeon No supraclavicular lymph node involvement palpation , biopsy , radiograph ( great 1.5 cm ) No distant metastases PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 02 Patients ECOG 2 must consider good candidate study treat oncologist Life expectancy At least 12 week Hematopoietic Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great 1.5 time upper limit normal ( ULN ) AST great 3 time ULN Renal Creatinine great 1.5 time ULN Cardiovascular No New York Heart Association class III IV heart disease Other No uncontrolled infection No severe underlie disease would preclude study participation No grade 2 great peripheral neuropathy Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy esophageal cancer Endocrine therapy Not specify Radiotherapy No prior radiotherapy anticipate field study radiotherapy Surgery Not specify Other No concurrent diuretics No concurrent amifostine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>adenocarcinoma stomach</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
</DOC>